DCGI panel to review today SII applications for Covovax’s use among kids aged 2-7 years, 7-11 years Read more
Biological E gets WHO nod to be additional facility for making Johnson & Johnson COVID vaccine Read more
Researchers devise age-based eligibility method to measure vaccine effectiveness in data-deficient scenarios Read more